Naïve ESCs are readily achieved by adding two chemical inhibitors (MEK1 inhibitor: iMEK1 and GSK3β inhibitor: iGSK3β) upon exposure of leukemia inhibitor factors (LIF; hereafter LIF/2i) with bME [5]. This evidence concerns the gene MAP2K1 and leukemia.